Synvista Therapeutics, Inc.
Records under this name other than patents Synvista Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Synvista Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,511,036 | Dihydrothiazine prodrugs of thiazolium agents Lapsed on the fee record Ended Mar 31, 2013 · USPTO record | Lapsed on the fee record | Ended Mar 31, 2013 | USPTO record |
| US 7,432,254 | Method for treating glaucoma IC Lapsed on the fee record Ended Oct 7, 2012 · USPTO record | Lapsed on the fee record | Ended Oct 7, 2012 | USPTO record |
| US 6,506,902 | Synthesis of thiazolium compounds Lapsed on the fee record Ended Jan 14, 2011 · USPTO record | Lapsed on the fee record | Ended Jan 14, 2011 | USPTO record |
| US 6,440,749 | Method of treating certain indications associated with hyperglycemia Lapsed on the fee record Ended Aug 27, 2010 · USPTO record | Lapsed on the fee record | Ended Aug 27, 2010 | USPTO record |
| US 7,022,719 | Preventing and reversing the formation of advance glycosylation endproducts Lapsed on the fee record Ended Apr 4, 2010 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2010 | USPTO record |
| US 5,656,261 | Preventing and reversing advanced glycosylation endproducts Term ended Term ended no later than Aug 12, 2017 · Low confidence | Term ended | Term ended no later than Aug 12, 2017 | Low confidence |
| US 5,853,703 | Preventing and reversing the formation of advanced glycosylation endproducts Term ended Term ended no later than Dec 29, 2018 · Low confidence | Term ended | Term ended no later than Dec 29, 2018 | Low confidence |
| US 6,007,865 | Reversing the formation of advanced glycosylation endproducts Term ended Term ended no later than Dec 28, 2019 · Low confidence | Term ended | Term ended no later than Dec 28, 2019 | Low confidence |